Volume 22, Number 5—May 2016
Research
Acute Human Inkoo and Chatanga Virus Infections, Finland
Table 3
Patient no. | IgG IFA titer | IgM IFA titer | PCR result | Underlying illness | Reason for medical care | PRNT titer |
||
---|---|---|---|---|---|---|---|---|
INKV | CHATV | TAHV | ||||||
1 | 160 | 160 | Neg | – | Hospitalized (unknown infection)† | 320 | 40 | 40 |
2 | 80 | 40 | Neg | – | Hospitalized (unknown infection)† | 320 | 640‡ | 40 |
3 | 120 | 40 | Neg | – | Hospitalized (unknown infection)† | 320 | 40 | 40 |
4 | >640 | >320 | Neg | Hypertension | Hospitalized (unknown infection)† | 320 | 20,480 | 5,120 |
5§ | 160 | +/ND¶ | ND | – | Hospitalized (unknown infection)† | ND | ND | ND |
6§ | 320 | +/ND¶ | ND | – | Hospitalized (unknown infection)† | ND | ND | ND |
7 | 80 | >320 | Neg | Type 2 diabetes, hypertension | Fever (unknown infection)† | >640 | 40 | 80 |
8 | 320 | 40 | Neg | – | No information | 320 | <20 | <20 |
9 | 80 | 80 | Neg | Asthma, immunodeficiency | No information | 160 | 40 | <40 |
10 | 40 | 20 | ND | Hypothyroidism | Follow-up visit (suspected MS, neurologic disorder) | 160 | 20 | 40 |
11 | 320 | >320 | Neg | – | Follow-up visit (recurrent respiratory tract infections for 4 mo, suspected immunodeficiency) | 320 | 40 | 80 |
12 | <20 | 40 | Neg | Schizophrenia, hypothyroidism | Follow-up visit (HSV eye infection, rash, Steven-Johnson syndrome) | 320 | 20 | 40 |
13 | 160 | 120 | Neg | – | Hospitalized, acute infection (E. coli urosepsis) | 160 | 40 | 40 |
14 | <20 | 120 | Neg | MS disease, hypothyroidism | Hospitalized, acute infection (HSV infection) | >640 | <20 | 20 |
15 | 320 | 120 | Neg | – | Hospitalized, acute infection (impetigo contagiosa) | 640 | 40 | 40 |
16 | 960 | 40 | ND | – | Hospitalized, multiple infarcts in the central nervous system | 1,280 | 5,120 | 1,280 |
17 | 80 | 30 | Neg | – | Hospitalized, epidemic nephropathy | 320 | <20 | <20 |
*CHATV, Chatanga virus; HSV, herpes viruses; IFA, indirect immunofluorescence; INKV, Inkoo virus; MS, multiple sclerosis; ND, PCR not done; PRNT, plaque reduction neutralization test; TAHV, Tahyna virus; –, no underlying illness.
†Full patient history describing INKV or CHATV infection.
‡4-fold difference between titers was not achieved with neutralization test, the diagnostic criterion used to confirm CHATV infection.
§INKV infection confirmed by hemagglutination inhibition test and neutralization test earlier in Helsinki University Central Hospital laboratory.
¶Samples tested were IgM positive, but titer was not tested.
Page created: April 13, 2016
Page updated: April 13, 2016
Page reviewed: April 13, 2016
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.